Biotechnology has been one of the hottest areas for investors over the last five years due to the advent of multiple game-changing new medicines, and the ever-expanding human population that’s putting a tremendous amount of pressure on healthcare systems worldwide. That said, there have been several relatively unsuccessful endeavors in biotech such as cancer vaccines, gene therapy, and others, illustrating the need to choose wisely when it comes to this rapidly emerging space.